Task: Answer Verification
Input (English): Question: Does adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy improve overall survival of patients with stage III colon cancer?
Answer: For patients with stage III colon cancer, the addition of ED to FU-based therapy had no statistically significant effect on OS.
Output (English): no